Glass Vials: Market Size & Forecast 2026

The global glass vials market reached approximately USD 10.8 billion in 2025 (base year), growing at a 5.2% CAGR through 2032 to an estimated USD 15.4 billion. The category sits in a structurally tight balance: biologics demand (GLP-1 agonists, monoclonal antibodies, cell-and-gene therapies) is pulling converted-vial volume through RTU nested formats at 12-15% CAGR, while the underlying tubing supply remains concentrated among four producers. Tubing input cost accounts for 30-40% of finished converted-vial cost, and silica-sand plus soda-ash pricing has drifted upward roughly 8-12% since 2022, pushing converters to pass through 15-20% price hikes in the 2023-2024 contract cycle. > **Analyst Take.** The consensus 5%+ CAGR on glass vials is credible, but the composition is wrong: biologics are driving all the growth, and the thing nobody talks about is that the RTU nested-vial premium (2-4

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.